Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

19.73 -0.37 (-1.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Apellis Pharmaceuticals Stock Slips Despite Q2 Sales Beat Thanks To Syfovre, Empaveli ↗

July 31, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) reported a second quarter (Q2) EPS loss of $1.02, beating the

Via Benzinga

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2023

Gainers

Via Benzinga

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

July 31, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 30 Months in Patients with Geographic Atrophy (GA)

July 30, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Where Apellis Pharmaceuticals Stands With Analysts ↗

July 18, 2023

Via Benzinga

Earnings Scheduled For July 31, 2023 ↗

July 31, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.

Via Benzinga

Apellis Provides Update on Review of Rare Safety Events with SYFOVRE® (pegcetacoplan injection) for Geographic Atrophy

July 29, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 28, 2023

Via Benzinga

Alphabet, Boeing, Union Pacific And Other Big Stocks Moving Higher On Wednesday ↗

July 26, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown ↗

July 25, 2023

The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results

July 24, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗

July 21, 2023

But all the major indexes are at or near 15-month highs.

Via Investor's Business Daily

APLS Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Investors

July 21, 2023

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

July 20, 2023

During Thursday's session, 40 stocks hit new 52-week lows.

Via Benzinga

Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target ↗

July 20, 2023

Since Friday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares have plummeted around 50% after the stock came under pressure following the disclosure of

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 20, 2023

Via Benzinga

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS

July 18, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 18, 2023

Via Benzinga

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 18, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Via Benzinga

Why Are Apellis Pharmaceuticals Shares More Down 20% Today? ↗

July 17, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares are trading lower amid safety concerns regarding the company's newly launched Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 17, 2023

Via Benzinga

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

Ford Motor, AT&T, Frontier Communications And Other Big Stocks Moving Lower On Monday ↗

July 17, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session. Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares...

Via Benzinga

Apellis Pharma Crashes After Safety Report Undercuts Its Newest Eye Drug ↗

July 17, 2023

Now, investors are questioning the future for Apellis' Syfovre, an eye-disease treatment.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 17, 2023

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

All News about Apellis Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today